The Figs healthcare apparel stock (NYSE: FIGS) rose about 13% on October 12, 2026, a sharp move for a scrubwear company that trades on growth expectations. Traders are framing the rally around steady scrubwear demand and international expansion, though the durable test will be the next earnings report, not one session's price action.
Key Takeaways
- The move: FIGS gained roughly 13% on October 12, 2026, which makes it a momentum candidate rather than a confirmed trend change.
- The thesis: bulls point to repeat healthcare-worker purchases and overseas expansion; bears point to slow U.S. growth and tariff-exposed costs.
- The next catalyst: third-quarter results, typically reported in early November, will show whether the story is in the numbers.
- The risk: a one-day gap without a confirmed catalyst can fade quickly, especially in a stock that has often drawn heavy short interest.
Why Is the Figs Healthcare Apparel Stock Up 13% Today?
FIGS was one of the stronger movers in consumer discretionary on Monday. A double-digit gain in a name like this usually comes from some mix of fresh information, short covering and a shift in sector sentiment. Which of those dominated matters for how much conviction to put behind the move.
What we can confirm, and what we cannot
The price move is the confirmed fact. We have not tied it to a specific company-issued announcement, and we are not going to invent one. If FIGS published a press release, guidance change or SEC filing, it will appear on the FIGS investor relations site and on SEC EDGAR. Check both before you build a trade around a narrative you read secondhand.
Why a 13% move is not unusual for FIGS
FIGS went public in May 2021 at $22 a share and has traded well below its early post-IPO highs since. A stock that has de-rated that far, with a modest float of public Class A shares and a history of elevated short interest, tends to move hard when sentiment flips. Check the current short-interest figure before assuming covering played a role, because it changes with every reporting cycle.
Scrubwear Demand Surge: What the Business Actually Sells
The phrase "scrubwear demand surge" gets used loosely, so it helps to be specific. FIGS sells premium scrubs and related apparel directly to healthcare professionals. Its customers wear the product for long shifts and tend to own several sets, which supports repeat purchases. The company says it serves more than two million active customers, and the model depends on keeping them buying.
That is the strength of the model. Scrubs wear out, healthcare employment keeps growing over the long run, and brand loyalty in a profession where people spend 12 hours a day in the product is real. The weakness is competition. Medline, Cherokee-style legacy uniform brands, newer direct-to-consumer labels and mass-market retailers all sell scrubs at lower price points. FIGS has to defend a premium price with fit, fabric and community, and any sign of promotional discounting would pressure margins.
FIGS Earnings Growth: What the Q3 Report Needs to Show
Strong price action without matching fundamentals rarely lasts. When FIGS reports, three data points will decide whether FIGS earnings growth is accelerating or just stabilizing.
Revenue and active customers
Look at net revenue growth against the prior year, and then at active customers and revenue per customer. Growth that comes from new buyers is healthier than growth that comes from price increases or heavy promotion. Management's full-year outlook matters as much as the quarter itself, since the stock is likely to trade on the guidance range.
Gross margin, tariffs and inventory
FIGS has historically run a gross margin close to 70%, high for apparel. That cushion is why tariffs matter. The company relies on contract manufacturing in Asia, and import duties on apparel have been a recurring headwind across the group. Watch how much of any cost increase was absorbed versus passed on, and whether inventory levels look clean. Rising inventory ahead of the holiday period would be a yellow flag.
Profitability and cash
Adjusted EBITDA and free cash flow show whether FIGS can fund its expansion internally. A company with a strong balance sheet can keep investing through a slow quarter. A company without one cannot.
International Growth: Real Opportunity, Real Execution Risk
International expansion is the second leg of the bull case. FIGS already sells beyond the U.S., and the long-term argument is simple: healthcare workers exist in every market, and the brand has built its identity in the U.S. first. If overseas sales grow faster than the home market, the revenue mix improves.
The execution risks are equally concrete. Entering new countries means local marketing spend, shipping and returns costs, currency swings and different workplace dress norms. In many health systems, uniforms are supplied by the employer, which weakens the direct-to-consumer model. That is why investors should watch the disclosed share of revenue from outside the U.S. and the growth rate there, rather than treating "international" as an automatic positive.
Healthcare Uniform Stocks: How FIGS Compares
FIGS has few pure-play public peers, so traders who want sector exposure look at adjacent healthcare uniform stocks with very different business models. The comparison below is qualitative by design.
| Company (ticker) | Business model | Healthcare exposure | Main sales channel |
|---|---|---|---|
| FIGS (FIGS) | Premium scrubs and apparel brand | Nearly all of revenue | Direct to consumer, online |
| Superior Group of Companies (SGC) | Uniforms, plus promotional products and contact center services | Meaningful through its healthcare uniform brands | Wholesale and B2B |
| Cintas (CTAS) | Uniform rental, facility and safety services | Small part of a diversified base | Route-based B2B rental |
| UniFirst (UNF) | Uniform rental and workwear | Limited | Route-based B2B rental |
The takeaway: FIGS carries the purest exposure to scrubwear demand, but also the most volatile earnings and the least contractual revenue. Rental companies trade on recurring contracts. FIGS trades on whether customers keep choosing it.
How to Trade the Figs Healthcare Apparel Stock Rally Without Chasing
A 13% gap invites the worst habit in trading: buying the highest print because it feels like confirmation. A more disciplined approach starts with the tape. Did volume expand well beyond the recent average? Did the stock hold above its opening range, or did it fade into the close? Did it hold above the prior day's close if it gaps down the next morning? Those answers say more than the headline percentage.
If you want to see how this move compares with other names, the Pre-Market Rockets scanner lists top pre-market gainers along with their catalysts, and the Momentum + Volatility scanner helps rank whether FIGS is an outlier or one of many strong tapes. For sector context, other healthcare names have also moved sharply on their own catalysts recently, such as Humana's Star Ratings rebound, though those are managed-care stories with different drivers than scrubwear.
Position size should reflect the stock's volatility. Define your exit before entry, and decide in advance whether you are trading the gap or holding into the November earnings release. Those are different trades with different risk. Our broader market analysis articles cover how to plan around event risk.
What Could Go Wrong for FIGS Shares?
- No fundamental catalyst: if the rally was sentiment or short covering, it can reverse as quickly as it formed.
- Tariffs and costs: higher import duties compress margins unless the company raises prices, which risks volume.
- Core U.S. growth: if domestic demand is flat, international gains may not offset it.
- Competition and discounting: a premium brand cannot hold prices if rivals compete on price.
- Consumer spending: scrubs are a need for the profession, but premium brands are still a choice.
None of this makes the Figs healthcare apparel stock a bad idea after a strong day. It does mean the bar for the next report is higher than it was last week. The sensible stance is to track the company's own disclosures, watch whether buyers defend the gap, and let the November numbers, not Monday's candle, decide whether this is a trend or a bounce.
This article is for informational purposes only and is not investment advice. Verify all figures against company filings before trading.
Frequently Asked Questions: Figs healthcare apparel stock
Why is FIGS stock up today?
FIGS shares rose about 13% on October 12, 2026. Market commentary links the move to scrubwear demand and international growth, but traders should confirm any company-specific catalyst in the latest press release or 8-K on the FIGS investor relations site or SEC EDGAR before treating a single explanation as fact.
What does FIGS Inc. sell?
FIGS is a direct-to-consumer healthcare apparel company. It sells scrubs, lab coats, outerwear, activewear and related accessories to doctors, nurses and other healthcare professionals, mainly through its website and app. It went public on the NYSE in May 2021 under the ticker FIGS.
When does FIGS report its next earnings?
FIGS has typically reported third-quarter results in early November. The company announces the exact date and conference call details ahead of time on its investor relations website, so check there for the confirmed 2026 schedule before positioning around the report.
What are the main risks of buying FIGS after a 13% jump?
The main risks are chasing a gap that fades, tariff-driven cost pressure on imported apparel, slowing growth in the core U.S. business, and competition from uniform makers and retailers. Stocks with heavy short interest can also reverse quickly once short covering ends.
Track Live Signals: Real-time momentum scanner, unusual volume alerts and AI-powered stock signals at TDVW Scanner. Track $FIGS on Yahoo Finance.
Not financial advice. Always do your own research.